The role of screening for adverse drug effects, depression, and anxiety

Click the link to see a research article exploring how screening for adverse AED (Anti-Epileptic Drug) effects, depression and anxiety could improve quality of life for people with epilepsy.

The research was conducted using the following (summarised) method:

Patients were screened for quality of life (using QOLIE-31), major depressive disorder (MDD) (NDDI-E), generalised anxiety disorder (GAD) (GAD-7), and AED Effects (AEP). Then, dimensional (NDDI-E and GAD-7 scores) and categorical (MDD and GAD) analyses were performed to investigate interactions between quality of life and AED Effects.